Kv7 Potassium Channels
Kv7 Potassium Channels - Related Videos
11:02
Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography
0 Views •
Cited by 8 •
2012
Measurements of Kv7 (KCNQ) potassium channel activity in isolated arterial myocytes (using patch clamp electrophysiological techniques) in parallel with measurements of constrictor/dilator responses (using pressure myography) can reveal important information about the roles of Kv7 channels in vascular smooth muscle physiology and pharmacology.
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
0 Views •
Cited by 20 •
2013
Methods for developing and validating a quantitative fluorescence assay for measuring the activity of inward rectifier potassium (Kir) channels for high-throughput compound screening is presented.
01:20
Antiepileptic Drugs: Potassium Channel Activators
0 Views •
2024
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy. Ezogabine has gained approval as an adjunctive treatment...
10:59
Use of Label-free Optical Biosensors to Detect Modulation of Potassium Channels by G-protein Coupled Receptors
0 Views •
Cited by 5 •
2014
Optical biosensor techniques can detect changes in mass near the plasma membrane in living cells and allow one to follow cellular responses in both individual cells and populations of cells. This protocol will describe detection of the modulation of potassium channels by G-protein coupled receptors in intact cells using this approach.
01:12
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
0 Views •
2024
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
FAQs
When depolarization activates these channels, potassium exits the cell and generates an outward current. This current counteracts electrical excitation by helping stabilize the membrane potential. In excitable cells, that stabilizing effect can limit the tendency to fire repeatedly, making Kv7 activity important for controlling the strength and duration of electrical signaling.
The M-current produced by Kv7.2/Kv7.3 channels activates slowly, so its influence develops over time rather than immediately at the start of depolarization. This timing allows the current to shape ongoing neuronal excitability and synaptic responsiveness. Consequently, the channel pair contributes to how neurons regulate sustained or repetitive electrical activity.
KCNQ gene products form the molecular basis of Kv7 channels, but their biological importance extends across several excitable tissues. In neurons, Kv7.2/Kv7.3 channels support the M-current, whereas Kv7 channels also participate in cardiac activity and hearing. Studying these channels therefore connects gene products with tissue-specific electrical functions.
Because Kv7 activity stabilizes membranes and limits repetitive neuronal firing, altered channel function can influence disorders associated with abnormal excitability. The supplied context identifies epilepsy and pain as important research areas. Investigators can therefore examine Kv7 channels and their modulation when exploring how electrical signaling contributes to these conditions or how targeted therapies might be developed.
A broad investigation can compare neuronal signaling with electrical activity in muscle and cardiac tissue, as well as processes involved in hearing. These systems represent distinct biological settings in which membrane excitability matters. Examining Kv7 channels across them helps relate a common channel family to different physiological roles and research questions.
Research on channel modulation can show how changing Kv7 activity affects membrane stability, repetitive firing, and synaptic responsiveness. Those outcomes provide a functional basis for evaluating whether Kv7 channels are useful therapeutic targets. The relevance is especially clear in research on epilepsy, pain, and other disorders linked to abnormal electrical signaling.